Product Information
ETRAVIRINE 200 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $11.4115 per EA under NDC 60219172206. Its NADAC has been published 210 times since Jun 22, 2022.
Strength
200 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219172206
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETRAVIRINEApproval Type
Generic (ANDA)
FDA Application
ANDA214196On Market Since
6/14/2021
Pharmacological Classes
Price Statistics
The NADAC for ETRAVIRINE 200 MG TABLET has been published 210 times since Jun 22, 2022, and over the history we have for it it has declined 35.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4115 per EA |
|---|---|
| All-time high | $17.7091 (Mar 15, 2023) |
| All-time low | $11.2785 (May 20, 2026) |
| 52-week high | $12.8167 |
| 52-week low | $11.2785 |
| Median price | $13.2688 |
| Average price | $14.2572 |
| Largest weekly change | +13.4% (Oct 23, 2024) |
| Weeks tracked | 210 |
| Tracking since | Jun 22, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ETRAVIRINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ETRAVIRINE 200 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $11.4115 per EA (NDC 60219172206), effective Jun 24, 2026.
How has the price of ETRAVIRINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for ETRAVIRINE 200 MG TABLET has declined 35.6%. It has been tracked across 210 weekly CMS publications since Jun 22, 2022.
What are the highest and lowest recorded NADAC prices for ETRAVIRINE 200 MG TABLET?
Since Jun 22, 2022, the NADAC for ETRAVIRINE 200 MG TABLET has ranged from a low of $11.2785 (May 20, 2026) to a high of $17.7091 (Mar 15, 2023), with a median of $13.2688 per EA.
Are there cheaper alternatives to ETRAVIRINE 200 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ETRAVIRINE 200 MG TABLET, but none are currently priced below it.
Who manufactures ETRAVIRINE 200 MG TABLET?
ETRAVIRINE 200 MG TABLET (NDC 60219172206) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification